Inactive Instrument

News ONCODESIGN

Equities

ALONC

FR0011766229

Summary

Unlock all the news: Be the first to know and act before the market!

Oncodesign Société Anonyme(ENXTPA:ALONC) dropped from Next Biotech Index	22-12-21	CI
ONCODESIGN : Franchissement de seuil	22-10-26	PU
Oncodesign Services Names Successors as Chairman/CEO Departs	22-10-19	MT
Oncodesign Services Shareholders Sell Majority Stake to Edmond de Rothschild Fund	22-10-19	MT
ONCODESIGN : Inside Information / Operations of the issuer (acquisitions, sales...)	22-10-19	PU
Oncodesign Precision Medicine to List Directly on Euronext Access + Paris	22-10-05	MT
Oncodesign Société Anonyme completed the Spin-Off of Oncodesign Precision Medicine Société anonyme.	22-10-04	CI
Oncodesign Société Anonyme completed the Spin-Off of Oncodesign Precision Medicine Société anonyme.	22-10-04	CI
The General Meeting of Oncodesign authorises the allocation of Oncodesign Precision Medicine shares to Oncodesign shareholders	22-10-03	AQ
Euronext Paris authorises the listing of Oncodesign Precision Medicine shares on Euronext Access + in connection with the allocation of OPM shares to Oncodesign shareholders	22-09-29	AQ
Oncodesign Unit Gains Approval To List On Euronext Access + In Paris	22-09-29	MT
Oncodesign Société Anonyme agreed to Spin-Off Oncodesign Precision Medicine.	22-09-27	CI
Parkinson, Servier exercises the exclusive licensing option on collaborative program with Oncodesign Precision Medicine	22-09-27	AQ
Oncodesign : announces its results for the first half of 2022	22-09-15	PU
Oncodesign Société Anonyme Announces Planned Separation of Its Two Business Areas	22-07-01	CI
Oncodesign Société Anonyme Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-07	CI
Sengine Precision Medicine and Oncodesign Announce Collaboration Agreement for the Discovery of New Personalized Cancer Treatment for Aggressive and Untreatable Tumors	22-02-08	CI
Oncodesign Société Anonyme Reports Turnover Results for the Year Ended December 31, 2021	22-01-27	CI
Oncodesign Société Anonyme's Equity Buyback announced on February 15, 2021, has expired.	21-12-23	CI
Oncodesign Strengthens the Intellectual Property of ODS 101 in Treating Inflammatory Bowel Disease	21-11-04	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News ONCODESIGN

Equities

ALONC

FR0011766229

Summary

Filters